The Discounted Cash Flow (DCF) valuation of Axsome Therapeutics Inc (AXSM) is (106.50) USD. With the latest stock price at 116.49 USD, the upside of Axsome Therapeutics Inc based on DCF is -191.4%.
Based on the latest price of 116.49 USD and our DCF valuation, Axsome Therapeutics Inc (AXSM) is a sell. selling Axsome stocks now will result in a potential gain of 191.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.1% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (231.80) - (70.93) | (106.50) |
| Upside | -299.0% - -160.9% | -191.4% |